Correlation Between ImmuPharma PLC and Rheinmetall
Can any of the company-specific risk be diversified away by investing in both ImmuPharma PLC and Rheinmetall at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuPharma PLC and Rheinmetall into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmuPharma PLC and Rheinmetall AG, you can compare the effects of market volatilities on ImmuPharma PLC and Rheinmetall and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuPharma PLC with a short position of Rheinmetall. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuPharma PLC and Rheinmetall.
Diversification Opportunities for ImmuPharma PLC and Rheinmetall
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ImmuPharma and Rheinmetall is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ImmuPharma PLC and Rheinmetall AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rheinmetall AG and ImmuPharma PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuPharma PLC are associated (or correlated) with Rheinmetall. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rheinmetall AG has no effect on the direction of ImmuPharma PLC i.e., ImmuPharma PLC and Rheinmetall go up and down completely randomly.
Pair Corralation between ImmuPharma PLC and Rheinmetall
If you would invest 62,030 in Rheinmetall AG on October 24, 2024 and sell it today you would earn a total of 9,990 from holding Rheinmetall AG or generate 16.11% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
ImmuPharma PLC vs. Rheinmetall AG
Performance |
Timeline |
ImmuPharma PLC |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
Rheinmetall AG |
ImmuPharma PLC and Rheinmetall Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ImmuPharma PLC and Rheinmetall
The main advantage of trading using opposite ImmuPharma PLC and Rheinmetall positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuPharma PLC position performs unexpectedly, Rheinmetall can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rheinmetall will offset losses from the drop in Rheinmetall's long position.ImmuPharma PLC vs. Sparebank 1 SR | ImmuPharma PLC vs. Ion Beam Applications | ImmuPharma PLC vs. Commerzbank AG | ImmuPharma PLC vs. GlobalData PLC |
Rheinmetall vs. United Airlines Holdings | Rheinmetall vs. International Consolidated Airlines | Rheinmetall vs. Pets at Home | Rheinmetall vs. Eastman Chemical Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |